20% OFF
Maball Rituximab 500mg Injection

Maball Rituximab 500mg Injection

$238.20
$297.75
  
Availability : In Stock
Delivery To:
 
Delivery in 10 to 15 Business Days*

Rituximab Maball 500mg Injection is a potent injectable that treats several disorders. Inflammatory illnesses and cancer are the most common. This treatment uses rituximab. Targeting disables immune cell surface proteins. The medicine targets malignant B-cells in autoimmune disorders such as rheumatoid arthritis, lupus, and vasculitis, treating chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Clinical professionals administer intravenous injections. Treatment dosage and frequency depend on patient's condition and response. Rituximab Maball, 500 mg side effects are prevalent. Infection, low blood cell counts, fever, and infusion responses can result after injections.

Introduction To Rituximab Maball 500mg Injection

Maball gives 500 mg rituximab. Intravenous medicine treats many malignancies and autoimmune diseases. A binding causes an action. Proteins destroy or silence B cells, which contribute to many diseases. 

An IV doctor at a hospital administers Rituximab Maball Injection. Dosage and frequency may be changed based on the patient's condition and response to treatment.  

How Does Rituximab Maball 500mg Injection Works 

Maball-administered 500 mg rituximab To act, monoclonal antibodies must target CD20 on B cells upon injection. B lymphocytes combat disease. Rituximab binds to CD20 and leads to B cell apoptosis. Specific B cells die by ADCC.

Rituximab Injection lowers B lymphocytes. This controls aberrant immune responses in rheumatoid arthritis, non-Hodgkin's lymphoma, and CLL. Rituximab controls immune cell function and disrupts inflammatory signaling pathways, helping autoimmune diseases. Rituximab Maball 500 mg Injection improves therapy and prognosis in autoimmune illnesses and cancers by reducing abnormal immune responses. Kills CD20-positive B lymphocytes.

Rituximab Maball 500mg Injection - Uses

Rituximab Maball 500 mg mostly treats cancer and autoimmune diseases. The 500 mg Rituximab Uses for these key reasons:

  • NHL (Lupus vulgaris): 

Maball gives Rituximab 500 mg for non-Hodgkin's lymphoma, a lymphatic malignancy treated by shots. Attacking and eliminating malignant B cells reduces mortality and disease transmission.

  • Long-term lymphocytic leukemia:

It treats chronic lymphocytic leukemia, a blood and bone marrow cancer. Rituximab 500 mg from Maball Injections reduces blood cancer cells, relieving symptoms and preventing progression.

  • RA joint pain:

Doctors may administer Rituximab Maball 500mg Injection when other rheumatoid arthritis treatments fail. It targets B-cells, which damage and inflame joints, to treat rheumatoid arthritis.

  • GPA and MPA:

Maball-administered 500 mg rituximab Inflammatory illnesses granulomatosis with polyangiitis and microscopic polyangiitis expand blood vessels. These diseases typically require injections.

  • Other immune-system diseases:

Other inflammatory illnesses may be treated with Rituximab Maball 500mg off the label. Injections can treat MS, pemphigus vulgaris, SLE, and the other illnesses indicated.

Only a doctor should administer Rituximab Maball 500 mg Injection for safety. It can produce serious negative effects and is not for everyone.


Rituximab Maball 500mg Injection - Dosage

This monoclonal antibody addresses cancer and autoimmune diseases. This optimizes results and prevents negative effects. Typically, Rituximab 500mg of body surface area is sufficient for IV Rituximab (MabThera) administration. However, the dose may vary depending on the condition, patient weight, past health issues, and treatment efficacy. 

The process determines Rituximab's amount and timing with non-Hodgkin's lymphoma chemotherapy. Rituximab alone or with additional medications treats inflammatory diseases including rheumatoid arthritis. A hospital or clinic doctor or nurse administers the long-lasting infusion. Antihistamines, corticosteroids, and other medications may be administered before surgery to reduce infusion adverse effects.

Rituximab injections must be done according to the doctor's instructions for dosage, timing, and technique. Medication safety and efficacy are compromised when patients miss doses or change treatment programmes without permission.


Other Dosage of Rituximab Maball 500mg Injection
Rituximab Maball 500mg Injection - Side Effects and Precautions

Rituximab Drug, commercialized as Maball 500 mg injectable, is a potent cancer and inflammatory disease treatment. Be wary of the side effects; it can assist some conditions if you follow these guidelines. The immune system can be damaged by rituximab, making it problematic. Rituximab destroys B cells, which have specialized immune system functions, making it a good monoclonal antibody. This reduces infection resistance but helps autoimmune illnesses caused by a busy immune system. 


Patients should know the negative effects and reduce their intensity. Healthcare practitioners must regularly monitor patients and encourage open communication to safely and efficiently provide rituximab.

Rituximab Maball 500mg Injection vs. Other Medicines 

Comparing Rituximab Maball 500mg Injection with Adalimumab (Humira):



Feature
Rituximab Maball 500mg Injection
Adalimumab (Humira)
Brand Names
Maball, Rituxan, MabThera
Humira
Dosage Form
Intravenous injection
Subcutaneous injection
Typical Dosage
375 mg/m² IV weekly for 4-8 weeks (varies by condition)
40 mg subcutaneously every other week
Approved Uses
Non-Hodgkin's, Rheumatoid arthritis, CLL, Polyangiitis-granulomatosis, Vulgar Pemphigus
Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Plaque psoriasis, Juvenile idiopathic arthritis


Check Rituximab Maball 500mg injection at Indogenmed and order the tablets at a low cost with secure packaging now.

FAQ's of Rituximab Maball 500mg Injection
Ratings and Reviews